G\u00f3mez-Acebo & Pombo leads Sanitas’ legal advice on an innovative oncology project following its investment in MIMO Biosciences.<\/h4>\n\n\n\n
G\u00f3mez-Acebo & Pombo has advised Sanitas on its investment in MIMO Biosciences (Modelling Immunotherapy In Oncology), a spin-off of CIMA University of Navarra.<\/p>\n\n\n\n
Sanitas, a company specialising in healthcare, joins forces with two private investors in the field of research and becomes a shareholder in the MIMO Biosciences project, a spin-off company arising from the research results obtained at the CIMA University of Navarra, focused on cancer immunotherapy, over the last twelve years. Its mission is to provide preclinical research services based on unique models that recapitulate a wide range of genetic alterations of different haematological malignancies, including multiple myeloma and lymphomas.<\/p>\n\n\n\n
This is a framework agreement for health research, in the first phase of which new models will be developed to accelerate the development of immunotherapy drugs for different types of haematological cancers.<\/p>\n\n\n\n
The G\u00f3mez-Acebo & Pombo team was formed by \u00c1lvaro Mateo, Patricia P\u00e9rez and Rodrigo Fern\u00e1ndez-Chill\u00f3n, partners and associates in the Corporate and Commercial practice; Borja Carvajal and Irene Fern\u00e1ndez Puyol, partners in the Public and Regulated Sectors practice; Luis Cuesta and Pablo Soler, associates in the Tax practice; Silvia Mu\u00f1oz, associate in the Intellectual Property practice; and Borja Gonz\u00e1lez Elejabarrieta, Natalia Mestres, associate in the Labour and Employment practice.<\/p>\n\n\n\n
![\"icon\"](\"https:\/\/ga-pstg.servidortemporal.net\/wp-content\/themes\/ga-p\/assets\/images\/external-icon.svg\"){kind=icon}
<\/div><\/a>\n <\/div>\n\n\n\n<\/p>\n\n<\/div>\n<\/div>\n\n\n
\n <\/span>\n \u00c1lvaro Mateo Sixto<\/a>\n – Partner<\/span>\n <\/p>\n \n <\/span>\n Patricia P\u00e9rez<\/span>\n – Associate<\/span>\n <\/p>\n <\/div>\n \n <\/span>\n Borja Carvajal<\/a>\n – Partner<\/span>\n <\/p>\n \n <\/span>\n Irene Ferna\u0301ndez Puyol<\/a>\n – Partner<\/span>\n <\/p>\n \n <\/span>\n Luis Cuesta<\/a>\n – Partner<\/span>\n <\/p>\n \n <\/span>\n Pablo Soler<\/a>\n – Senior Associate<\/span>\n <\/p>\n \n <\/span>\n Silvia Mu\u00f1oz<\/span>\n – Associate<\/span>\n <\/p>\n \n <\/span>\n Borja Gonz\u00e1lez Elejabarrieta<\/a>\n – Counsel<\/span>\n <\/p>\n <\/div>\n \n <\/span>\n Deal<\/span>\n <\/p>\n <\/div>\n \n \n <\/span>\n Corporate and M&A<\/a>\n <\/p>\n \n <\/span>\n Tax<\/a>\n <\/p>\n \n <\/span>\n Public Law and Regulated Sectors<\/a>\n <\/p>\n \n <\/span>\n Employment<\/a>\n <\/p>\n \n <\/span>\n Intellectual Property<\/a>\n <\/p>\n <\/div>\n <\/div>\n<\/div>\n\n<\/div>\n<\/div>\n\n<\/div>\n\n <\/div>\n\n<\/div>\n\n\n <\/p>\n","protected":false},"excerpt":{"rendered":" G\u00f3mez-Acebo & Pombo has advised Sanitas on its investment in MIMO Biosciences (Modelling Immunotherapy In Oncology), a spin-off of CIMA University of Navarra.<\/p>\n","protected":false},"featured_media":0,"template":"","categoria":[117],"class_list":["post-324898","noticia","type-noticia","status-publish","hentry","categoria-deal-en"],"acf":[],"yoast_head":"\n![\"icon\"](\"https:\/\/ga-pstg.servidortemporal.net\/wp-content\/themes\/ga-p\/assets\/images\/arrow-down-flu-color.svg\"){kind=icon}
<\/div>\n <\/div>\n <\/div>\n \n ![\"icon\"](\"https:\/\/ga-pstg.servidortemporal.net\/wp-content\/themes\/ga-p\/assets\/images\/arrow-left-primary.svg\"){kind=icon}
\n <\/a>\n See next ![\"icon\"](\"https:\/\/ga-pstg.servidortemporal.net\/wp-content\/themes\/ga-p\/assets\/images\/arrow-right-primary.svg\"){kind=icon}
\n <\/a>\n <\/div>\n <\/div>\n<\/div>\n<\/div>\n\n<\/div>\n\n <\/div>\n\n<\/div>\n\n\n\n